![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, December 30, 2023 10:02:18 AM
Member Level
Re: ae kusterer post# 660233
Saturday, December 30, 2023 10:01:33 AM
Post#
660241
of 660241
Wrong. Instead, Marnix Bosch last publicly spoke on November 17 at SNO. Les’s Big BIz interview was given four to five weeks after that (according to Les in the interview), and the interview was aired one to two weeks after that.
I’m looking forward to this 2 hour #SNO2023 poster presentation by Drs. Linda Liau, Keyoumars Ashkan & Marnix Bosch of $NWBO, tonight 11/17/23 from 7:30PM to 9:30PM. They will talk about further findings regarding T cell response in #DCVax-L Phase 3 trial: https://t.co/JyVxbriILq pic.twitter.com/tqG3myXB6t
— ATLnsider (@ATLnsider) November 17, 2023
Saturday, December 30, 2023 3:11:32 AM
Post#
660207
of 660245
Les Goldman is on the Big Biz Show discussing proteomics ....
Big Biz Show - 12-29-23
Min 21.45s
https://www.biztalkradio.com/players/individuals/
ae kusterer
Re: None
Friday, July 14, 2023 3:31:00 PM
Post#
609892
of 660244
beartrap
https://www.biztalkradio.com/players/individuals/
The http link below works. Les begins at 24 min. He’s slow talking but well worth hearing even the description of how DCs works. At the end he states they have 1.7 mill pages of application which they are reviewing before application to 4 countries with UK being the first. Les made clear that they go from application to commercialization, with no comment of doubt. He made a significant comment about backlogs at Sawston for DCVax and how UK has allowed them to sell the treatment before approval. It sounds like the application is all together and in the review stage . Well worth hearing with your own eats! Also at the end, Les talks about teaming up with other businesses and it being about how much they will pay us….
Interesting points during the Big Biz Show with Les Goldman, VP of $NWBO. Thanks for the link
@HenryMuney
https://t.co/UDQipCADv4;;
✅“Dendritic cell…bigger thing than our inventors realized at the time…it’s the artificial intelligence of our immune system"
✅We are in the processs of finalizing our applications (plural)
✅First application is to the MHRA
✅MAA 1.7m pages long, 27 modules
✅“Applying to other places that gave us permission to do the trial. Four different countries including the UK, including Canada, including Germany…filing in order…" (4th country is not named, but I assume the USA)
✅Dealing with issues related to depressed stock price
✅DCVax-L combined with other products (that have no efficacy on their own) enhance the results. Les stated re: combos “we will be doing plenty of that as well”
✅Referenced some trial in the works with prostrate cancer (not sure if referencing old trial plans)
✅Will you take it to the finish line or will a bigger company come in and take over? Question at end was very interesting - my take, they are looking to partner/licensee with multiple suitors in different areas
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM